Schade – dieser Artikel ist leider ausverkauft. Sobald wir wissen, ob und wann der Artikel wieder verfügbar ist, informieren wir Sie an dieser Stelle.
  • Format: PDF

T is is the f rst edition of Pediatric Lymphomas. T e ment of both Hodgkin and non-Hodgkin lymphomas, editors have been colleagues for more than 25 years and lymphoproliferative disorders associated with - and have been involved in the design and coordination munodef ciency. In addition, three chapters focus on of clinical trials and multimodality approaches for the pathology, molecular biology, and genetics of children with Hodgkin and non-Hodgkin lymphomas. Hodgkin and non-Hodgkin lymphoma including the Progress in elucidating the pathogenesis and in the di- rare cutaneous lymphomas. We hope…mehr

Produktbeschreibung
T is is the f rst edition of Pediatric Lymphomas. T e ment of both Hodgkin and non-Hodgkin lymphomas, editors have been colleagues for more than 25 years and lymphoproliferative disorders associated with - and have been involved in the design and coordination munodef ciency. In addition, three chapters focus on of clinical trials and multimodality approaches for the pathology, molecular biology, and genetics of children with Hodgkin and non-Hodgkin lymphomas. Hodgkin and non-Hodgkin lymphoma including the Progress in elucidating the pathogenesis and in the di- rare cutaneous lymphomas. We hope that Pediatric agnosis and treatment of lymphomas in children has Lymphomas will be a useful resource for practitioners been one of the great success stories in pediatric oncol- from the many dif erent disciplines involved in the ogy. Prior to 1970, fewer than 20% of children with comprehensive care of children with lymphomas. malignant lymphomas survived. Today, more than T e authors are all leading experts in the area of 90% of children diagnosed with Hodgkin lymphoma childhood lymphomas. We wish to thank them for all survive and more than 80% of children with non- of the time and ef ort that went into their contribu- Hodgkin lymphoma are considered cured. Continued tions. If this f rst edition is helpful to our diverse re- improvement in survival has occurred as the result of ership, it is because of the authors.
Autorenporträt
Howard J. Weinstein, Harvard Medical School, Boston, MA, USA / Melissa M. Hudson, St. Jude Children's Research Hospital, Memphis, TN, USA / Michael P. Link, Stanford University, Palo Alto, CA, USA
Rezensionen
From the reviews:

"This slim book contains nearly everything a practicing oncologist needs to know about the pathogenesis, diagnosis, therapy, and delayed complications of pediatric lymphomas. ... Overall, this book is an exceptional, highly accessible resource for oncologists or anyone caring for children and adolescents who are receiving treatment for lymphoma or are in long-term follow-up. ... The general principles and the specific pearls, tables, and figures are illuminating and helpful for all who are interested in understanding pediatric lymphomas." (Leslie S. Kersun and Beverly J. Lange, The New England Journal of Medicine, July, 2007)

"This book covers the epidemiology, pathology, molecular biology, clinical features, diagnosis, and treatment of Hodgkin and non-Hodgkin lymphomas in children and adolescents. ... it is written at a level most appropriate for pediatric oncologists and perhaps, hematopathologists. ... it might be added to libraries as a reference for pediatricians in-training to use when they manage these patients. ... The quality of this book is excellent ... . It will be an important quick read for pediatric oncologists to prepare for their boards or recertification." (Russell Steele, Doody's Book Reviews, October, 2007)

"This is a multicenter treatise reviewing updated knowledge on the genetics, diagnosis, treatment and sequelae of lymphomas in childhood. The book is divided into 12 chapters ... . Clearly written, with many illustrations and tables in color, and extensive references after each chapter. For pediatric oncologists and general pediatricians." (Pediatric Endocrinology Reviews, Vol. 5 (3), March, 2008)
…mehr